Skip to main content
. 2016 Dec 9;34(2):253–261. doi: 10.1007/s10815-016-0853-7

Table 2.

Effect estimates (95% CI) for follicular fluid (FF) and urine essential trace elements with IVF outcomes among women

IVF endpoints Essential trace elements
Co Cr Cu Mn Mo Zn
FF (n = 44)
 Total oocytesa −0.14 (−0.60, 0.32) −0.10 (−0.53, 0.33) 0.75 (−0.10, 1.60) 0.01 (−0.25, 0.026) 1.1 × 10−3 (−0.49, 0.48) 0.11 (−0.69, 0.91)
 Proportion M2-oocytesb, c, d −0.34 (−0.70, 0.20) −0.51 (−0.82, −0.20) * 0.18 (−0.57, 0.92) −0.14 (−0.30, 0.02) 0.04 (−0.25, 0.34) −0.37 (−0.88, 0.15)
 Proportion oocytes fertilizedb, c 0.04 (−0.15, 0.24) −0.09 (−0.25, 0.06) −0.04 (−0.36, 0.29) −0.04 (−0.13, 0.06) 0.03 (−0.14, 0.21) −0.30 (−0.58, −0.02) *
 Total embryosa, e −0.02 (−0.54, 0.51) −0.11 (−0.57, 0.35) 0.50 (−0.35, 1.35) −0.06 (−0.33, 0.20) 0.21 (−0.27, 0.69) −0.11 (−0.94, 0.71)
 Mean EFSb, c, f −0.18 (−0.58, 0.22) −0.15 (−0.44, 0.15) −0.42 (−1.00, 0.15) −4.0 × 10−3 (−0.19, 0.18) 1.0 × 10−3 (−0.33, 0.34) −0.36 (−0.92, 0.20)
 Mean ECNb, c, e −0.39 (−0.75, −0.04) * 0.16 (−0.16, 0.48) 0.04 (−0.58, 0.65) −0.03 (−0.21, 0.15) 0.27 (−0.06, 0.60) −0.22 (−0.81, 0.36)
 Endometrial thicknessb, c, f 0.20 (0.03, 0.37) * 0.02 (−0.14, 0.18) 0.18 (−0.17, 0.52) 0.02 (−0.08, 0.12) −0.06 (−0.24, 0.13) 0.08 (−0.23, 0.38)
 Implantatione, g 1.40 (0.55, 3.59) 0.93 (0.30, 2.89) 0.47 (0.16, 1.41) 0.75 (0.42,1.37) 1.08 (0.39, 3.00) 0.43 (0.10, 1.85)
 Pregnancye, g 1.42 (0.51, 3.95) 1.19 (0.39, 3.60) 0.42 (0.12, 1.46) 0.73 (0.36, 1.48) 1.13 (0.32, 4.02) 0.51 (0.09, 2.78)
 Live birthe, g 1.59 (0.47, 5.35) 1.63 (0.53, 5.06) 0.32 (0.07, 1.47) 0.90 (0.41, 1.96) 1.71 (0.52, 5.58) 0.75 (0.12, 4.63)
Urineh (n = 43)
 Total oocytesa, b 0.28 (0.07, 0.49) * 0.49 (0.19, 0.78) * 0.31 (0.16, 0.47) * 0.22 (4.0 × 10 −3 , 0.45) * 0.31 (0.11, 0.50) * 0.19 (−0.01, 0.40)
 Proportion M2-oocytesb, c, d −0.02 (−0.24, 0.20) 0.14 (−0.08, 0.35) −0.06 (−0.22, 0.09) 0.10 (−0.11, 0.30) 0.07 (−0.16, 0.30) 0.01 (−0.32, 0.58)
 Proportion oocytes fertilizedb, c 0.03 (−0.09, 0.14) 0.10 (−0.02, 0.22) −0.04 (−0.13, 0.04) 1.0 × 10−3 (−0.12, 0.12) −0.02 (−0.14, 0.11) 0.01 (−0.08, 0.09)
 Total embryosa, e 0.27 (0.05, 0.48) * 0.47 (0.15, 0.79) * 0.23 (0.06, 0.39) * 0.34 (0.09, 0.59) * 0.29 (0.09, 0.49) * 0.22 (0.02, 0.42) *
 Mean EFSb, c, f 0.05 (−0.16, 0.25) 0.07 (−0.19, 0.33) −0.02 (−0.17, 0.14) 0.02 (−0.21, 0.25) 1.02 × 10−3 (−0.23, 0.23) −0.03 (−0.19, 0.13)
 Mean ECNb, c, e 0.15 (−0.05, 0.36) 0.20 (−0.05, 0.45) 0.15 (1.7 × 10 −3 , 0.30) * 0.05 (−0.19, 0.28) 0.17 (−0.06, 0.40) 0.08 (−0.08, 0.24)
 Endometrial thicknessb, c, f 0.07 (−0.05, 0.18) 0.06 (−0.07, 0.19) 3.0 × 10−3 (−0.09, 0.09) −0.02 (−0.15, 0.12) 1.11 × 10−3 (−0.13, 0.13) 0.01 (−0.08, 0.10)
 Implantatione, g 0.88 (0.56, 1.37) 0.64 (0.35, 1.19) 0.90 (0.62, 1.29) 0.17 (0.59, 2.29) 0.05 (0.68, 1.61) 0.78 (0.52, 1.18)
 Pregnancye, g 0.76 (0.45, 1.49) 0.89 (0.44, 1.82) 0.81 (0.54, 1.21) 1.16 (0.50, 2.71) 0.90 (0.53, 1.53) 0.85 (0.51, 1.41)
 Live birthe, g 0.66 (0.37, 1.19) 0.85 (0.36, 2.36) 0.71 (0.45, 1.12) 1.03 (0.40, 2.67) 0.80 (0.40, 1.59) 0.69 (0.35, 1.32)

NOTE: Statistically significant effects (P < 0.05) in boldface type

ECN embryo cell number, EFS embryo fragmentation score, M2 metaphase-2 arrest

aNegative binomial regression coefficients with natural log-transformed essential elements as predictors and adjusted for age, BMI, race, and cigarette smoking

bNatural log-transformed value

cLinear regression coefficients with natural log-transformed essential elements as predictors and adjusted for age, BMI, race, and cigarette smoking

dIntracytoplasmic sperm injection (ICSI) only (n = 33)

e n = 2 missing values

f n = 3 missing values

gModified Poisson regression relative risks with natural log-transformed essential elements as predictors and adjusted for age, race, and cigarette smoking

hAdditional adjustment for urine creatinine (mg/dL)

* P < 0.05